To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1597504
Sale price1.080,81 €
|
Quininone (50 mg) (Cinchonan-9-one, 6'-methoxy-, (8alpha)-) |
R20280 | 84-31-1 | 1.080,81 € | |
|
USP-1598020
Sale price1.163,77 €
|
Rabeprazole Related Compound A (25 mg) (Sodium 1-(1H-benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate) |
R21410 | NA | 1.163,77 € | |
|
USP-1598031
Sale price1.107,68 €
|
Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) |
R08090 | 924663-38-7 | 1.107,68 € | |
|
USP-1598042
Sale price1.081,98 €
|
Rabeprazole Related Compound C (25 mg) (1H-Benzimidazole-2-thiol) |
F1M253 | 583-39-1 | 1.081,98 € | |
|
USP-1598053
Sale price1.107,68 €
|
Rabeprazole Related Compound D (25 mg) (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole) |
R188U0 | 117976-47-3 | 1.107,68 € | |
|
USP-1598064
Sale price1.076,14 €
|
Rabeprazole Related Compound E (25 mg) (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole) |
F1M255 | 117977-21-6 | 1.076,14 € | |
|
USP-1598075
Sale price1.008,37 €
|
Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) |
R08050 | 168167-42-8 | 1.008,37 € | |
|
USP-1598234
Sale price1.028,23 €
|
Raloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate) |
R068X0 | 195454-31-0 | 1.028,23 € | |
|
USP-1598267
Sale price3.352,26 €
|
Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide) |
F050W0 | 1193687-87-4 | 3.352,26 € | |
|
USP-1598314
Sale price963,97 €
|
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(Methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
G1H441 | 108313-11-7 | 963,97 € | |
|
USP-1598323
Sale price1.034,07 €
|
Ramipril Related Compound B (20 mg) ((2S,3aS,6aS)-1-{[(S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
R172P0 | 295328-72-2 | 1.034,07 € | |
|
USP-1598338
Sale price1.028,23 €
|
Ramipril Related Compound C (20 mg) ((2S,3aS,6aS)-1-{[(S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid hydrochloride) |
R172H0 | 885516-61-0 | 1.028,23 € | |
|
USP-1598347
Sale price979,16 €
|
Ramipril Related Compound D (20 mg) (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate) |
R161B0 | 108731-95-9 | 979,16 € | |
|
USP-1598507
Sale price1.055,10 €
|
Ranitidine Related Compound A (50 mg) (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate) |
R06290 | 256948-32-0 | 1.055,10 € |
